Compass Therapeutics, Inc. (CMPX) vs Precision BioSciences, Inc. (DTIL)
A side-by-side comparison of Compass Therapeutics, Inc. and Precision BioSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CMPX
Compass Therapeutics, Inc.
$0.96HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DTIL
Precision BioSciences, Inc.
$6.31HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CMPX vs DTIL
growth of $100 · dividends reinvested · last 6yCMPX -88.7% (-30.5%/yr)DTIL -98.0% (-47.9%/yr)CMPX compounded faster over this window
Log scale — wide-divergence pair
CMPX DTIL
CMPX vs DTIL: by the numbers
- •DTIL is the larger company ($174M vs $173M market cap).
- •Both run net losses; CMPX's is the smaller (0.00% vs -117.04% net margin).
Metrics side by side
Valuation
| Metric | CMPX | DTIL |
|---|---|---|
| P/S ratio | N/A | 3.87 |
| P/B ratio | 1.04 | 3.85 |
Profitability
| Metric | CMPX | DTIL |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -152.19% |
| Net margin | 0.00% | -117.04% |
| ROE | -44.23% | -116.42% |
| ROIC | -46.59% | -30.23% |
Growth (annualized)
| Metric | CMPX | DTIL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.13% |
| Total return CAGR (5Y) | -22.79% | -54.84% |
Frequently asked
- How have CMPX and DTIL total returns compared?
- Over the past 5 years, CMPX delivered -22.79% and DTIL delivered -54.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.